Dr. Maria Susana Ortiz Urda, MD

Dr. Ortiz Urda practices at Santa Barbara Skin Institute in Santa Barbara, California.

Dr. Ortiz Urda's NPI, 1154574853, was assigned on October 28, 2008. Dr. Ortiz Urda holds California license A105136.

Dr. Ortiz Urda's primary practice is Santa Barbara Skin Institute, at 2921 De La Vina St, Santa Barbara, CA 93105-3309. The practice phone is (805) 770-3999.

Dr. Ortiz Urda's primary practice is Santa Barbara Skin Institute in Santa Barbara, California. Dr. Ortiz Urda is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is Santa Barbara Skin Institute. Dmand AI also links Dr. Ortiz Urda to 3 more medical groups, 2 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ortiz Urda practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Ortiz Urda's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Ortiz Urda is licensed in California.

CMS data shows 4,509 Medicare services from Dr. Ortiz Urda across 11 procedure codes in 2024, for 908 Medicare patients. Medicare paid $169,081 for them.

CMS counts 908 Medicare patients who saw Dr. Ortiz Urda in 2024. The largest group is 65 to 74, with 452 patients. 74% of them have high cholesterol, and 56% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ortiz Urda's median patient age at 62, with 59% women.

In 2024, Dr. Ortiz Urda wrote 724 Medicare Part D claims for 307 patients. 99% of them were for generic drugs. CMS names the drug for 694 of them, across 19 drugs with 11 or more claims each, at $18,867 in total drug cost. In 2023, CMS named 813 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Ortiz Urda for performance year 2024, reported as part of a group. Dr. Ortiz Urda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ortiz Urda as offering telehealth. CMS counts 1,610 procedures of removal of skin lesions by Dr. Ortiz Urda, more than 97% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 38 general payments to Dr. Ortiz Urda from 7 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $398.